THE ASSOCIATION BETWEEN TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASES: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v8i11.1433Keywords:
Type 2 diabetes, Cardiovascular Disease, Association, CorrelationAbstract
Aim: The objective of this study is to evaluate the complication of dorsal plication and ventral lengthening technique for penile curvature.
Methods: A systematic search strategy was conducted across several electronic reference databases (PubMed, Cochrane Library, ProQuest) and included articles published between 2001–2022. Duplicate publications, review articles, and incomplete articles were excluded.
Results: Databases searching identified a total of 254 articles. Of these, 29 articles passed the screening process and resulted in 12 articles for full-text assessment. The 6 articles did not evaluate the outcome of interest. Hence, we found six appropriate studies included in this review.
Conclusion: There exists an association between T2DM and CVD. As the incidence of DM continues to rise, it is also possible that the incidence of CVD will increase as a result of both the conventional risk factors for DM and the direct effect of DM on CVD. DM and CVD are on the rise, and their prevalence and progression must be slowed by DM and CVD treatment and control. To improve medical treatment and cardiovascular outcomes for patients with diabetes, additional research is essential to increase understanding of the disease state and its impact on CV function.
References
Perreault L, Boardman MK, Pak J. The Association Between Type 2 Diabetes and Cardiovascular Disease: The “For Your SweetHeartTM” Survey. Adv Ther [Internet]. 2019;36(3):746–55. Available from: https://doi.org/10.1007/s12325-019-0871-9
Caussy C, Aubin A, Loomba R. The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk. Curr Diab Rep. 2021;21(5).
Yun JS, Ko SH. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes. Metabolism [Internet]. 2021;123:154838. Available from: https://doi.org/10.1016/j.metabol.2021.154838
Goodarzi MO, Rotter JI. Genetics Insights in the Relationship between Type 2 Diabetes and Coronary Heart Disease. Circ Res. 2020;1526–48.
Henning RJ. Type-2 diabetes mellitus and cardiovascular disease. Future Cardiology. 2018.
Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol [Internet]. 2022;21(1):1–15. Available from: https://doi.org/10.1186/s12933-022-01516-6
Joseph JJ, Deedwania P, Acharya T, Aguilar D, Bhatt DL, Chyun DA, et al. Comprehensive Management of Cardiovascular Risk Factors for Adults with Type 2 Diabetes: A Scientific Statement from the American Heart Association. Vol. 145, Circulation. 2022. 722–759 p.
Sugden M, Holness M. Pathophysiology of diabetic dyslipidemia?: implications for atherogenesis and treatment Pathophysiology of diabetic dyslipidemia?: implications for atherogenesis and treatment. Clin Lipidol. 2017;4299.
Vesa CM, Popa L, Popa AR, Rus M, Zaha AA, Bungau S, et al. Current data regarding the relationship between type 2 diabetes mellitus and cardiovascular risk factors. Diagnostics. 2020;10(5).
Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1·9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105–13.
Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet [Internet]. 2015;47(11):1236–41. Available from: http://dx.doi.org/10.1038/ng.3406
Gan W, Bragg F, Walters RG, Millwood IY, Lin K, Chen Y, et al. Genetic predisposition to type 2 diabetes and risk of subclinical atherosclerosis and cardiovascular diseases among 160,000 Chinese adults. Diabetes. 2019;68(11):2155–64.
Zhang L, Yang H, Yang P. The Correlation between Type 2 Diabetes Mellitus and Cardiovascular Disease Risk Factors in the Elderly. Appl Bionics Biomech. 2022;2022.
Zhao M, Song L, Sun L, Wang M, Wang C, Yao S, et al. Associations of type 2 diabetes onset age with cardiovascular disease and mortality: The Kailuan study. Diabetes Care. 2021;44(6):1426–32.
Hu C, Lin L, Zhu Y, Zhang Y, Wang S, Zhang J, et al. Association Between Age at Diagnosis of Type 2 Diabetes and Cardiovascular Diseases: A Nationwide, Population-Based, Cohort Study. Front Endocrinol (Lausanne). 2021;12(October):1–9.
Sharma A, Mittal S, Aggarwal R, Chauhan MK. Diabetes and cardiovascular disease: inter-relation of risk factors and treatment. Futur J Pharm Sci. 2020;6(1).
Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol [Internet]. 2018;17(1):1–19. Available from: https://doi.org/10.1186/s12933-018-0728-6
Schmidt AM. Diabetes Mellitus and Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2019;39(4):558–68.
De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links. Front Endocrinol (Lausanne). 2018;9(JAN):1–13.
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics’2017 Update: A Report from the American Heart Association. Vol. 135, Circulation. 2017.
McAlister FA, Zheng Y, Westerhout CM, Buse JB, Standl E, McGuire DK, et al. Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial. Eur J Heart Fail. 2020;22(11):2026–34.
Vesa CM, Popa AR, Bungau S, Daina LG, Buhas C, Judea-Pusta CT, et al. Exploration of Insulin Sensitivity, Insulin Resistance, Early Insulin Secretion and ?-cell Function, and Their Relationship with Glycated Hemoglobin Level in Normal Weight Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Vol. 70, Revista de Chimie. 2019.
Bergheanu SC, Bodde MC, Jukema JW. Pathophysiology and treatment of atherosclerosis: Current view and future perspective on lipoprotein modification treatment. Vol. 25, Netherlands Heart Journal. 2017.
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Vol. 17, Cardiovascular Diabetology. 2018.
Eckel RH, Bornfeldt KE, Goldberg IJ. Cardiovascular disease in diabetes, beyond glucose. Cell Metab [Internet]. 2021;33(8):1519–45. Available from: https://doi.org/10.1016/j.cmet.2021.07.001
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Advance Research in Medical & Health Science
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
